Drug Trial Radar · NCT04685135
Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation
Last checked: Nov 20, 2026Latest source record: Aug 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
453
Actual
Start
Feb 23, 2021
Primary completion
Dec 30, 2023
Study completion Oct 30, 2026
Sponsor
- Lead sponsor
- Mirati Therapeutics Inc.Bristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Dec 28, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously treated for metastatic NSCLC with a KRAS G12C mutation.
Conditions
- Metastatic Non Small Cell Lung Cancer
- Advanced Non Small Cell Lung Cancer
Interventions
MRTX849Drug
21 day cycles
DocetaxelDrug
21 day cycles
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-Free Survival (PFS) as Per Blinded Independent Central ReviewTime frame: From randomization to the date of progression or death due to any cause, whichever occurs first (up to approximately 143 weeks)
Locations
380 sites in 24 countries. Site status is shown where the registry gives one.
Local Institution - 012-898
Cerritos, California
Local Institution - 012-910
Duarte, California
Local Institution - 012-898 D
Glendale, California
Local Institution - 012-910-A
Huntington Beach, California
Local Institution - 012-910-C
Irvine, California
Local Institution - 012-910-B
Long Beach, California
Local Institution - 012-910-F
Long Beach, California
Local Institution - 012-910-D
Newport Beach, California
Local Institution - 012-898 C
Santa Ana, California
Local Institution - 012-858
Santa Rosa, California
Local Institution - 012-910-E
Torrance, California
Local Institution - 012-951-B
Denver, Colorado
Local Institution - 012-951
Lafayette, Colorado
Local Institution - 012-872
Lone Tree, Colorado
Local Institution - 012-951-A
Wheat Ridge, Colorado
Local Institution - 012-562-B
Fleming Island, Florida
Local Institution - 012-968
Fort Lauderdale, Florida
Local Institution - 012-562-D
Jacksonville, Florida
Local Institution - 012-853
Jacksonville, Florida
Local Institution - 012-562-E
Jacksonville, Florida
Local Institution - 012-562-A
Jacksonville, Florida
Local Institution - 012-562-C
Jacksonville, Florida
Local Institution - 012-562-F
Jacksonville, Florida
Local Institution - 012-562-G
Jacksonville, Florida
Local Institution - 012-562
Jacksonville, Florida
Local Institution - 012-825
Miami Beach, Florida
Local Institution - 012-973
Orlando, Florida
Local Institution - 012-877
Pensacola, Florida
Local Institution - 012-839
Plantation, Florida
Local Institution - 012-941
Athens, Georgia
Local Institution - 012-835 - A
Austell, Georgia
Local Institution - 012-835 - B
Carrollton, Georgia
Local Institution - 012-835 - C
Cartersville, Georgia
Local Institution - 012-835 - D
Douglasville, Georgia
Local Institution - 012-835
Marietta, Georgia
Local Institution - 012-917
Chicago, Illinois
Local Institution - 012-972
Chicago, Illinois
Local Institution - 012-972 C
Harvey, Illinois
Local Institution - 012-972 A
New Lenox, Illinois
Local Institution - 012-883
Niles, Illinois
Showing 40 of 380 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.